Infectious Diseases I

Wound Infection

Anaya DA, Dellinger EP. Necrotizing soft-tissue infec-

tion: diagnosis and management. Clin Infect Dis.

2007;44(5):705-710. https://doi.org/10.1086/511638

Calderwood MS, Anderson DJ, Bratzler DW, et al.

Strategies to prevent surgical site infections in acute-care

hospitals: 2022 update. Infect Control Hosp Epidemiol.

2023;44(5):695-720. https://doi.org/10.1017/ice.2023.67

Dorazio J, Chiappelli AL, Shields RK, et al. Clindamycin

plus vancomycin versus linezolid for treatment of nec-

rotizing soft tissue infection. Open Forum Infect Dis.

2023;10(6):ofad258. https://doi.org/10.1093/ofid/ofad258

Lappin E, Ferguson AJ. Gram-positive toxic shock syn-

doi.org/10.1016/s1473-3099(09)70066-0

May AK, Stafford RE, Bulger EM, et al. Treatment of

complicated skin and soft tissue infections. Surg Infect

sur.2009.012

Sartelli M, Guirao X, Hardcastle TC, et al. 2018 WSES/

SIS-E consensus conference: recommendations for the

management of skin and soft-tissue infections. World

J Emerg Surg. 2018;13:58. https://doi.org/10.1186/

s13017-018-0219-9

Stevens DL, Bisno AL, Chambers HF, et al. Practice

guidelines for the diagnosis and management of

skin and soft tissue infections: 2014 update by the

Infectious Diseases Society of America. Clin Infect Dis.

2014;59(2):e10-e52. https://doi.org/10.1093/cid/ciu444

Influenza

Centers for Disease Control and Prevention. Signs and

symptoms of flu. 2024. https://www.cdc.gov/flu/signs-

symptoms/index.html

Centers for Disease Control and Prevention. Rapid influ-

enza diagnostic tests. 2024. https://www.cdc.gov/flu/hcp/

testing-methods/clinician_guidance_ridt.html

Centers for Disease Control and Prevention. FluView:

a weekly influenza surveillance report prepared by the

Influenza Division. https://www.cdc.gov/fluview/index.

html

Centers for Disease Control and Prevention. Influenza

antiviral medications: summary for clinicians. 2023.

https://www.cdc.gov/flu/hcp/antivirals/summary-clini-

cians.html

de Jong MD, Ison MG, Monto AS, et al. Evaluation of

intravenous peramivir for treatment of influenza in hos-

pitalized patients. Clin Infect Dis. 2014;59(12):e172-e185.

https://doi.org/10.1093/cid/ciu632

Flannery AH, Thompson Bastin ML. Oseltamivir

dosing in critically ill patients with severe influenza.

org/10.1177/1060028014535362

Harper SA, Bradley JS, Englund JA, et al. Seasonal

influenza in adults and children—diagnosis, treat-

ment, chemoprophylaxis, and institutional outbreak

management: clinical practice guidelines of the

Infectious Diseases Society of America. Clin Infect Dis.

2009;48(8):1003-1032. https://doi.org/10.1086/598513

Lansbury LE, Rodrigo C, Leonardi-Bee J, Nguyen-Van-

Tam J, Shen Lim W. Corticosteroids as adjunctive therapy

in the treatment of influenza: an updated Cochrane

Med.

2020;48(2):e98-e106.

https://doi.org/10.1097/

ccm.0000000000004093

Rothberg MB, Haessler SD. Complications of sea-

2010;38(4

suppl):e91-e97.

https://doi.org/10.1097/

ccm.0b013e3181c92eeb

Tsai MJ, Yang KY, Chan MC, et al. Impact of

corticosteroid treatment on clinical outcomes of influ-

enza-associated ARDS: a nationwide multicenter

org/10.1186/s13613-020-0642-4

Severe Acute Respiratory Syndrome Coronavirus 2

Alhazzani W, Evans L, Alshamsi F, et al. Surviving

Sepsis Campaign guidelines on the management of

adults with coronavirus disease 2019 (COVID-19) in the

https://doi.org/10.1097/ccm.0000000000004899

Beigel JH, Tomashek KM, Dodd LE. Remdesivir for the

treatment of Covid-19—preliminary report. Reply. N

Engl J Med. 2020;383(10):994. https://doi.org/10.1056/

nejmc2022236

Chen X, Zhu Y, Shen L, Zhou D, Feng N, Tong Q.

Efficacy and safety of nirmatrelvir/ritonavir in severe

hospitalized patients with COVID-19 and in patients at

high risk for progression to critical illness: a real-world

doi.org/10.1177/08850666241228841